The number of people with susceptibility test result for rifampicin in Naoero
Naoero: The number of people with susceptibility test result for rifampicin was 14 in 2021. ◆ Volatile
Latest (2021)
14
World rank
136th
of 155 countries
All-time high
14
in 2021
All-time low
0
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Naoero, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Naoero recorded 14 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.
Naoero ranks 136th of 155 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Naoero, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 14 | — |
Naoero compared with similar countries
- Naoero's 14 is below the median for high income countries, which is 142, 10% of the median. (61 countries reporting)
- Naoero's 14 is below the median for East Asia & Pacific, which is 185, 8% of the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0 | 0 | 0 | 3 |
| 2020s | 7 | 0 | 14 | 2 |
Countries ranked near Naoero
- 133 Tuvalu 19 compare
- 134 France 17 compare
- 135 New Caledonia 15 compare
- 136 Puerto Rico 14 compare
- 138 Bahamas 12 compare
- 139 Northern Mariana Islands 11 compare
More health data for Naoero
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8477 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,118 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2019)
- Population ages 00-04, female, annual growth rate -2.33 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0593 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.1333 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Naoero?
- The number of people with susceptibility test result for rifampicin in Naoero was 14 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Naoero?
- The highest recorded value was 14 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Naoero?
- The lowest recorded value was 0 in 2017.
- How does Naoero rank for the number of people with susceptibility test result for rifampicin?
- Naoero ranks 136th out of 155 countries with data for 2021.
- Where does this Naoero data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).